Tenapan aims to improve accessibility of diabetes treatment at an affordable cost
Delhi-based biotech firm Panacea Biotech introduces indigenously developed high quality antidiabetic drug 'Tenepan', used for treatment of Type 2 Diabetes Mellitus. Tenapan aims to improve accessibility of diabetes treatment at an affordable cost as part of the company's commitment to the 'Make in India' campaign.
Mr Rajesh Jain, Joint Managing Director, Panacea BioTech said. "Panacea BioTech has always endeavored to partner with medical practitioners in assisting to manage their patients better by introducing new innovative and good quality products."
With the launch of Tenepan the company intends to reach out to the patients with the latest therapeutic treatment.